Skip to main content

Find Clinical Trials

Home
Conditions
MMRd/MSI-H Stage II-III Endometrial Cancer

Clinical trial condition

MMRd/MSI-H Stage II-III Endometrial Cancer

Explore clinical trials studying MMRd/MSI-H Stage II-III Endometrial Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

MMRd/MSI-H Stage II-III Endometrial Cancer trial results

Not Yet Recruiting

Clinical Trial to Assess the Efficacy of Dostarlimab as Neoadjuvant Therapy in Patients With MMRd/MSI-H Stage II-III Endometrial Cancer

NCT07013851

Conditions: MMRd/MSI-H Stage II-III Endometrial Cancer
Locations: Grupo Español de Investigación en Cáncer Ginecológico (GEICO) Madrid, Spain

View Trial Details